Abclonal Biotechnology

Developer of protein and peptide reagents and kits for cell and molecular biology research

placeWoburn, Massachusetts, United States calendar_todayFounded 2006 groups12 employees language abclonal.com

Registered entities

Innovation

2 patent families — focus: Chemistry & metallurgy; filing pace slowing. Cited 15 times.

YearFilings
20212

Investor mix

11 investors on record; lead investors include Sequoia Capital China, Sequoia Capital, LYFE Capital, C&D; 1 has since exited.

Investor typeCountShare
Venture capital436%
Private equity218%
Bank & private debt19%
Other / undisclosed436%
Coming soon